SUN PHARMA ADVANCED RESEARCH COMPANY LTD. - 532872 - Audio Playback Of The Investor Call For Vodobatinik Parkinson''s Disease Program
As attached16-01-2024
SUN PHARMA ADVANCED RESEARCH COMPANY LTD. - 532872 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript
Please find enclosed herewith the transcript of the Investor call on PROSEEK Program held on January 6, 2024SUN PHARMA ADVANCED RESEARCH COMPANY LTD. - 532872 - Announcement under Regulation 30 (LODR)-Investor Presentation
Investor Presentation of 42nd Annual J.P. Morgan Healthcare ConferenceSUN PHARMA ADVANCED RESEARCH COMPANY LTD. - 532872 - Announcement under Regulation 30 (LODR)-Investor Presentation
Investor PresentationSUN PHARMA ADVANCED RESEARCH COMPANY LTD. - 532872 - Clarification On Price Movement
As attachedSUN PHARMA ADVANCED RESEARCH COMPANY LTD. - 532872 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
The Company would like to provide an update on Vodobatinib Parkinson's Disease program and in this connection an Investor Call has been scheduled on Saturday, January 6, 2024 at 5.00 pm.